Clinical Trial Update: Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation [Phase 2]

View source ↗

Summary

Phase 2 pilot study of belatacept for immunosuppression in lung transplant recipients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody-mediated Rejection
• Lung Transplant Rejection

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lung Transplant Rejection, Antibody-mediated Rejection | Phase 2 | Status: COMPLETED | Results posted: 2021-11-02